Lv1
68 积分 2024-11-24 加入
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
2天前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
29天前
已完结
Notes from the Field: Parvovirus B19 Activity — United States, January 2024–May 2025
1个月前
已完结
In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma
1个月前
已完结
Interfacial T cell engineering
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
2个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
2个月前
已完结
皖公网安备34019202002308
